Clinical Trial Update: Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve Subjects [Phase 4]

View source ↗

Summary

An open-label Phase 4 pilot trial is evaluating a regimen of darunavir boosted by cobicistat in combination with rilpivirine for treatment-naïve HIV-positive in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Edurant (rilpivirine)
• PREZISTA (darunavir)
• Tybost (Cobicistat)

Snippet

Sponsor: Therapeutic Concepts | Conditions: HIV Positive | Phase 4 | Status: UNKNOWN